SCHEMBL27180857

SCHEMBL27180857

Cc1cc(C)cc(NC(=O)c2ccc(NS(=O)(=O)c3ccc(F)c(Cl)c3)cc2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.65
▸ KMT2A Q03164 6/20 0.65
▸ LMNA P02545 4/20 0.65
▸ ALDH1A1 P00352 4/20 0.65
▸ MAPT P10636 3/20 0.65
▸ HTT P42858 2/20 0.60
▸ NPSR1 Q6W5P4 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ GPR27 Q9NS67 4/20 0.56
▸ SNCA P37840 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ PCTP Q9UKL6 1/20 0.50
▸ EGFR P00533 1/20 0.49
▸ FGFR1 P11362 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ PABPC1 P11940 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30926485 1.00 MEN1 (0.65) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL30926557 0.90 MEN1 (0.64) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL27180923 0.90 MEN1 (0.64) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL30926739 0.85 MEN1 (0.63) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL27180771 0.85 MEN1 (0.63) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL30926861 0.81 MEN1 (0.75) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL27179426 0.81 MEN1 (0.75) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL27180859 0.79 MAPT (0.63) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL30926496 0.79 MAPT (0.63) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL30926454 0.77 MAPT (0.63) MEN1KMT2ALMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885LMNA 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback